Status:
COMPLETED
SIB-Norwegian Version, Validation and Reliability Study
Lead Sponsor:
Sykehuset Innlandet HF
Conditions:
Dementia
Diagnostic Tests, Routine
Eligibility:
All Genders
Brief Summary
The purpose of this study is to validate and to test interrater reliability for the Norwgian version of Severe Impairment Battery (SIB).
Detailed Description
The study will include 60 persons with mild to severe dementia. To test the validation of SIB, we will interview the included persons with Severe Impairment Battery (SIB) and compare the results with ...
Eligibility Criteria
Inclusion
- Dementia, mild to severe.
- Nursing Home resident
Exclusion
- No ability to write or read.
- Physical handicapped, unable to use hands.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT00449384
Start Date
February 1 2007
End Date
May 1 2007
Last Update
July 3 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sykehuset Innlandet HF - Sanderud
Ottestad, Oppland, Norway, 2312